Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
drugs
5
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
5
×
startups
5
×
biotech
boston blog main
boston top stories
deals
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
fda
indiana blog main
indiana top stories
investing
national
synthetic biology
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
cystic fibrosis
What
bio
drug
roundup
companies
drugs
fda
admits
advance
ago
ahead
alzheimer’s
annual
approved
asco
assessed
attention
big
biologic
biology
biotech
biotechs
branded
choices
classes
combinator
commissioner
communities
conference
consumers
costly
counterweight
cytokine
demonstrating
diego’s
digital
disease
dug
elevatebio
enhanced
epidemic
Language
unset
Current search:
cancer
×
startups
×
drugs
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs